| 促红细胞生成素治疗肾性贫血的进展 |
| |
| 引用本文： | 程卫,李钟声. 促红细胞生成素治疗肾性贫血的进展[J]. 透析与人工器官, 2008, 19(3): 19-22 |
| |
| 作者姓名： | 程卫 李钟声 |
| |
| 作者单位： | 滁州市第一人民医院,滁洲,239000 |
| |
| 摘 要： | 促红细胞生成素（erythropoietin,EPO）主要是由肾脏产生的一种糖蛋白,用于调节红细胞的生成,它的缺乏导致贫血。重组促红细胞生成素（rHuEPO）治疗慢性肾衰引起的贫血是有效的和安全的。本文就促红细胞生成素的生理功能、临床应用和进展予以综述。
|
| 关 键 词： | 促红细胞生成素(EPO) 肾性贫血 慢性肾衰 |
The Application Advancement of Erythropoietin in Renal Anemia |
| |
| CHENG Wei,LI Zhong-sheng. The Application Advancement of Erythropoietin in Renal Anemia[J]. Chinese Journal of Dialysis and Artificial Organs, 2008, 19(3): 19-22 |
| |
| Authors: | CHENG Wei LI Zhong-sheng |
| |
| Affiliation: | ( The First Hospital of Chuzhou, Chuzhou 239000, China) |
| |
| Abstract: | Erythropoietin（EPO） is a kind of glycoprotein hormone, mainly produced by the kidney in the adult, which regulates red cell production. Lack of EPO leads to anemia. Treatment with recombinant human EPO （rHuEPO） is effective and safe in improving the management of the anemia associated with chronic renal failure. This paper summarizes the physiological function, clinical application and advancement of EPO. |
| |
| Keywords: | erythropoietin （EPO） renal anemia chronic renal failure |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
